AstraZeneca

AZN

Market cap $263B

COPPELL, Texas--(BUSINESS WIRE)--AstraZeneca today announces the unveiling of its newly-expanded, state-of-the-art manufacturing facility in Coppell, Texas. The expansion project will double the production of Lokelma for the benefit of patients in the United States and around the world. The investment of $445 million to expand the facility follows the groundbreaking last week at AstraZeneca's manufacturing facility in Albemarle County, Virginia. Both are part of AstraZeneca's $50 billion invest.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

AstraZeneca secures a three-year tariff break after striking a landmark U.S. deal to cut drug prices and expand its domestic manufacturing.

Following AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) agreement with the US government on 'most favoured nation' drug pricing at the end of last week, analysts said the discounts were not as big as some were expecting but will still hit profits. The White House announced the deal on Friday, after markets closed in New York, with confirmation of the deal shared with investors on Monday.

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, October 17-21, 2025. More than 95 abstracts will feature nine approved and nine potential new medicines from the Company including two abstracts featured in a late-breaking Presidential Symposium and 26 oral presentations. Key presentations include: DESTINY-Breast11 Pha.

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has become the second giant drugmaker to announce a drug pricing deal with the US government, after Pfizer's deal two weeks ago.  Pascal Soriot, the CEO of the Anglo-Swedish pharmaceutical group, met President Donald Trump on Friday to confirm a range of measures, including offering discounts of up to 80% on its medicines under prescriptions for chronic diseases and making its drugs available on the TrumpRx.gov direct purchasing platform.

AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices for millions of Americans.

President Trump details a new drug-pricing deal with AstraZeneca, and Fox News political analyst Lisa Boothe reacts on 'The Evening Edit.'

The Trump administration and AstraZeneca announced Friday they have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the U.S. The deal with AstraZeneca follows a similar pact with U.S. drugmaker Pfizer, which was announced late last month.